Psilocybin Safety Tolerability Healthy Older Adults Study
Summary
The National Institutes of Health registered a clinical trial (NCT07516405) evaluating psilocybin safety and tolerability in healthy older adults. The study will assess how this psychedelic compound is tolerated in subjects aged 60-85. Clinical trial sponsors and researchers should ensure proper registration and protocol compliance.
What changed
A new clinical trial registration appeared on ClinicalTrials.gov documenting a study on psilocybin safety and tolerability in healthy older adults (NCT07516405). The registration includes study objectives focused on evaluating how the psychedelic compound is tolerated in subjects aged 60-85.
Clinical trial sponsors, research institutions, and investigators involved in psychedelic medicine research should monitor this trial's progress. While the registration itself does not create immediate compliance obligations, studies involving Schedule I substances must maintain proper DEA licensing, IRB oversight, and FDA regulatory compliance throughout the research lifecycle.
What to do next
- Monitor ClinicalTrials.gov for protocol details and enrollment updates
- Verify proper DEA Schedule I handling procedures if involved in psychedelic research
- Track IRB approvals and FDA regulatory pathway for study progress
Archived snapshot
Apr 9, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Show glossary
Related changes
Get daily alerts for ClinicalTrials.gov
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov publishes new changes.